Is there any difference in the therapeutic effects of Levosimendan on advanced HFrEF patients with sinus rhythm or atrial fibrillation?

Patients with advanced heart failure have a high incidence of atrial fibrillation (AF) and develop into heart failure with reduced ejection fraction (HFrEF), and require higher doses of inotropes. However, it is uncertain about the differences in the effects of levosimendan in HFrEF patients with si...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenyan, Li, Fawen, Huang, Huihui, Wu, Xin, Tian, Weixiang, Yu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995919/
https://www.ncbi.nlm.nih.gov/pubmed/36910542
http://dx.doi.org/10.3389/fcvm.2023.1084300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995919/
https://www.ncbi.nlm.nih.gov/pubmed/36910542
http://dx.doi.org/10.3389/fcvm.2023.1084300

Ejemplares similares